Exact Mass: 498.1196
Exact Mass Matches: 498.1196
Found 296 metabolites which its exact mass value is equals to given mass value 498.1196
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N,N'-Bis(gamma-glutamyl)cystine
N,N-Bis(gamma-glutamyl)cystine is found in mushrooms. N,N-Bis(gamma-glutamyl)cystine is isolated from chives (Allium schoenoprasum) and from shiitake mushrooms (Lentinus edodes). Isolated from chives (Allium schoenoprasum) and from shiitake mushrooms (Lentinus edodes). N,N-Bis(gamma-glutamyl)cystine is found in mushrooms and onion-family vegetables.
3,4-Dicaffeoyl-1,5-quinolactone
3,4-Dicaffeoyl-1,5-quinolactone is a polyphenol compound found in foods of plant origin (PMID: 20428313)
Methyl 4,6-di-O-galloyl-beta-D-glucopyranoside
Gallotannin from Sanguisorba officinalis (burnet bloodwort). Methyl 4,6-di-O-galloyl-beta-D-glucopyranoside is found in tea and herbs and spices. Methyl 4,6-di-O-galloyl-beta-D-glucopyranoside is found in herbs and spices. Gallotannin from Sanguisorba officinalis (burnet bloodwort).
Artonol D
Artonol D is found in breadfruit. Artonol D is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol D is found in breadfruit and fruits.
Dukunolide B
Dukunolide B is found in fruits. Dukunolide B is from Lansium domesticum (langsat
Verproside
phylloflavan
5,8-dihydroxy-2-methyl[1,4]naphthoquinone-5-O-beta-xylopyranosyl-(1->6)-beta-glucopyranoside|diospyroside B
brianthein X
methyl 3,6-di-O-galloyl-beta-D-glucoside|Methyl-(O3,O6-digalloyl-beta-D-glucopyranosid)|methyl-(O3,O6-digalloyl-beta-D-glucopyranoside)
1-O-beta-D-(2,4-dihydroxy-6-methoxyphenyl)-6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-glucopyranoside
fucodiphloroethol G
A phlorotannin that consists of biphenyl-2,2,4,4,6-pentol substituted by a 2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy substituent at position 6. Isolated from the marine brown alga Ecklonia cava, it exhibits anti-allergic, antioxidant and hypoglycemic activities.
3,4,5-Trimethoxyphenyl-(6-O-galloyl)-O-EC-D-glucopyranoside
7-oxo-8,9-dihydroxy-4-N-demethyl-staurosporine trifluoroacetate
3-carboxy-5-hydroxy-6-O-beta-D-glucopyranosyl-7-phenyl-3H-benzo[de]isochromen-1-one
6-O-alpha-L-rhamnopyranosyl daphnogirin|6-O-alpha-L-rhamnopyranosyl-7-hydroxy-3-(7-methoxy-2-oxo-2H-1-benzopyran-8-yl)-2H-1-benzopyran-2-one
junceellonoid D|rel-(1R,2R,3R,4S,6R,7S,8S,9R,10R,14R,17R)-9,13-bis(acetyloxy)-4-chloro-3a,4,6,7,8,8a,9,10,11,12,12a,13-dodecahydro-7,8-dihydroxy-1,8a-dimethyl-5,12-dimethylene-5H-6,13a-epoxybenzo[1,5]cyclodeca[1,2-b]furan-2(1H)-one
2-[3,5-Dihydroxy-4-[3-hydroxy-5-(2,4,6-trihydroxyphenoxy)phenoxy]phenoxy]benzene-1,3,5-triol
1-(O-2,4,6-trimethoxyphenyl)-6-(O-galloyl)-beta-D-glucopyranoside|2,4,6-trimethoxyphenol 1-O-beta-D-(6-O-galloyl)-glucopyranoside
1-O-3,4,5-trimethoxyphenyl-(2-O-galloyl)-beta-D-glucopyranoside
3-O-(6-O-3,4,5-Trihydroxybenzoyl-beta-D-glucopyranoside)-3,4,5-Trihydroxybenzoic acid
3-(4-methoxyphenyl)-7-({6-O-[(E)-1-oxobut-2-en-1-yl]-beta-D-glucopyranosyl}oxy)-4H-1-benzopyran-4-one|4-methoxyisoflavone 7-O-beta-D-{6-[(E)-but-2-enoyl]}glycoside|ammopiptanoside A
4-O-glucopyranosyl-4,5-dihydroxy-2,2-dimethylpyran[5,6;6,7]isoflavone|alpinumisoflavone 4-O-beta-glucopyranoside
(2S)-dihydrotricin 4-O-(threo-beta-4-hydroxyphenylglyceryl) ether|calquiquelignan C
3-O-(beta-D-glucopyranosyluronic acid)-alpha-D-galactopyranuronic acid beta-L-rhamnopyranose 1,2:2,1-dianhydride
6,6-Diethyl-1,1,4,4,5,5,8,8-octahydroyx-[2,2-binaphthalene]-3,3,7,7-tetrone,9CI|7,7-bis(1,4,5,8-tetrahydroxy-3-ethylnaphthalene-2,6-dione)
Peonidin galactoside
Peonidin 3-O-galactoside is an anthocyanidin glycoside. Peonidin-3-O-galactoside chloride is an anthocyanin with antioxidant properties[1].
Silyamandin
Malvidin arabinoside
4,4-bis(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2-methoxybutanoic acid
C22H26O13_(1aS,1bS,2S,5aR,6S,6aS)-2-(beta-D-Glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl 3,4-dihydroxybenzoate
4,4-bis(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2-methoxybutanoic acid [IIN-based on: CCMSLIB00000848743]
4,4-bis(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2-methoxybutanoic acid [IIN-based: Match]
Cys Cys His His
Cys Asp Asp Phe
Cys Asp Phe Asp
Cys Asp Met Met
Cys Phe Asp Asp
Cys His Cys His
Cys His His Cys
Cys Met Asp Met
Cys Met Met Asp
Asp Cys Asp Phe
Asp Cys Phe Asp
Asp Cys Met Met
Asp Asp Cys Phe
Asp Asp Phe Cys
Asp Asp Ser Tyr
Asp Asp Tyr Ser
Asp Phe Cys Asp
Asp Phe Asp Cys
Asp Met Cys Met
Asp Met Met Cys
Asp Ser Asp Tyr
Asp Ser Tyr Asp
Asp Tyr Asp Ser
Asp Tyr Ser Asp
Phe Cys Asp Asp
Phe Asp Cys Asp
Phe Asp Asp Cys
His Cys Cys His
His Cys His Cys
His His Cys Cys
Met Cys Asp Met
Met Cys Met Asp
Met Asp Cys Met
Met Asp Met Cys
Met Met Cys Asp
Met Met Asp Cys
Met Met Met Ser
Met Met Ser Met
Met Ser Met Met
Ser Asp Asp Tyr
Ser Asp Tyr Asp
Ser Met Met Met
Ser Tyr Asp Asp
Tyr Asp Asp Ser
Tyr Asp Ser Asp
Tyr Ser Asp Asp
3,4-Dicaffeoyl-1,5-quinide
Dukunolide B
N-g-Glutamylcystine
Methyl 4,6-di-O-galloyl-b-D-glucopyranoside
4,4-Bis(6,8-dihydroxy-3-methyl-1-oxo-1H-isochromen-7-yl)-2-methoxybutanoic acid
Binifibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[(2-methoxy-4-nitrophenyl)azo]naphthalene-2-carboxamide
Methotrexate sodium
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
α,ω-Dihexylquaterthiophene,5,5μ-Bis(3-hexyl-2-thienyl)-2,2μ-bithiophene,DH-4T
[(2R,5R)-3-acetyloxy-5-[(5-cyano-6-phenylsulfanylpyridine-3-carbonyl)carbamoylamino]oxolan-2-yl]methyl acetate
Clobenoside
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
promethazine teoclate
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
[(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate
[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4]Bipyridinyl-4-Yl)-Methanone
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2,3-dihydroxybenzoyl)amino] hydrogen phosphate
(2S)-2-[6-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioate
7-oxo-8,9-dihydroxy-4-N-demethyl staurosporine
A indolocarbazole alkaloid that is 4-N-demethyl staurosporine substituted by hydroxy groups at positions 8 and 9 and an xo group at position 7. Isolated from Cystodytes solitus, it exhibits antineoplastic activity.
[4-[(E)-[(7-benzyl-1,3-dimethyl-2,6-dioxopurin-8-yl)hydrazinylidene]methyl]phenyl] furan-2-carboxylate
Cys-Cys-His-His
A tetrapeptide composed of two L-cysteine units joined to two L-histidine units by a peptide linkage.
allyl 3-deoxy-4-O-(3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl)-alpha-D-manno-oct-2-ulopyranosidonic acid
4-[bis(5-hydroxy-3-methyl-1H-pyrazol-4-yl)methyl]-2-ethoxyphenyl 4-methylbenzenesulfonate
alpha-Kdo-(2->8)-alpha-Kdo-OAll
A disaccharide derivative consisting of two 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl units joined via an alpha-(2->8)-linkage with an O-allyl group at the anomeric centre.
N-[4-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-5-methyl-2-thiazolyl]-2-(4-morpholinyl)acetamide
6-Chloro-3-[2-[4-[2,3-dihydro-1,4-benzodioxin-3-yl(oxo)methyl]-1-piperazinyl]-2-oxoethyl]-7-hydroxy-4-methyl-1-benzopyran-2-one
N-(4-chlorophenyl)-2-[3-(2-furanylmethyl)-4-imino-6,6-dimethyl-2-oxo-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-1-yl]acetamide
N-[4-(6-imidazo[2,1-b]thiazolyl)phenyl]-4-methoxy-3-(4-morpholinylsulfonyl)benzamide
[2-(4-Amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] 4-chloro-3-piperidin-1-ylsulfonylbenzoate
(2R)-2-azaniumyl-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxylato(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-oxido-2-oxoethanimidoyl]phenoxy}butanoate
4-Methyl-2-(6,13,15-trioxo-9-phenyl-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-en-14-yl)pentanoic acid
(1S,9R,10R,11R)-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-(3-methylphenyl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(1R,9S,10S,11S)-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-(3-methylphenyl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
[2-(5,7-Dihydroxy-4-oxo-2-phenyl-2,3-dihydrochromen-8-yl)-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulate
(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
4,4-Bis(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2-methoxybutanoic acid
alpha-Kdo-(2->4)-alpha-Kdo-OAll
A disaccharide derivative consisting of two 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl units joined via an alpha-(2->4)-linkage with an O-allyl group at the anomeric centre.
isonocardicin A(2-)
An oxime anion that is the major structure of isonocardicin A at pH 7.3.
nocardicin A(2-)
A dicarboxylic acid dianion that is the major structure of isonocardicin A at pH 7.3 (according to Marvin v 6.2.0.).
[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl furan-2-carboxylate
(5br,9r,9as,10s)-9-(3,4-dihydroxyphenyl)-10-(4-hydroxy-2-methoxyphenyl)-7-methyl-8,9,9a,10-tetrahydro-5bh-1,11-dioxatetraphen-2-one
(2r,3r)-7,9-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-12-methoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(2,4,6-trimethoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
1,3,3'-trihydroxy-1',2'-dimethoxy-2-methyl-9'h-[4,9'-bixanthen]-9-one
(1r,3s,5s,6r,7s,8r,10r,12s,13r,14r)-7-{[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-6,13,14-trihydroxy-12-methyl-2,4,9,11-tetraoxatricyclo[8.4.0.0³,⁸]tetradecane-5-carboxylic acid
4,4'-bis(2,4,6-trihydroxyphenoxy)-[1,1'-biphenyl]-2,2',6,6'-tetrol
(2s)-11-hydroxy-4-oxo-8-phenyl-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaene-2-carboxylic acid
4-[4-(3,4-dihydroxy-2-methoxy-6-methylbenzoyloxy)-2-hydroxy-6-methylbenzoyloxy]-2-hydroxy-6-methylbenzoic acid
(4as,12s,12as)-3-acetyl-4,4a,6,7,12,12a-hexahydroxy-9-methoxy-11-(3-methylbut-2-en-1-yl)-1,12-dihydrotetracene-2,5-dione
(3s)-3-[(2r,3r,4s,5r,6r)-4-(acetyloxy)-3-hydroxy-5-{[(2z)-2-isothiocyanatobut-2-enoyl]oxy}-6-methyloxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
3-[4-(3,5-dihydroxyphenoxy)-3,5-dihydroxyphenoxy]-[1,1'-biphenyl]-2,2',4,4',6,6'-hexol
(1r,2r,3s,4s,6r,8s,9r,10s,12s,14s,15r,18r)-10-(acetyloxy)-14-chloro-2-hydroxy-4,9,18-trimethyl-13-methylidene-17-oxo-5,16,19-trioxapentacyclo[10.6.1.0¹,¹⁵.0³,⁹.0⁴,⁶]nonadecan-8-yl acetate
[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-9-(acetyloxy)-5-[(1r)-1-bromo-2-hydroxyethyl]-3-hydroxy-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-1a-yl]methyl acetate
[(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-methoxy-3-(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(1s,18s,19s,20s)-19-ethenyl-18-{[(2s,3r,4s,5s,6s)-3,4,5,6-tetrahydroxyoxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-2(11),4,6,8,15-pentaene-10,14-dione
4-(2h-1,3-benzodioxol-5-yl)-6-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-naphtho[2,3-c]furan-1-one
(3r,4as,10ar)-3-chloro-10a-{[(1s,3s,6s)-3-chloro-6-hydroxy-2,2,6-trimethylcyclohexyl]methyl}-6,8-dihydroxy-2,2-dimethyl-3h,4h,4ah-naphtho[2,3-b]pyran-5,10-dione
6-galloylglucose; beta-d-pyranose-form,me glycoside,o-(3,4-dihydroxybenzoyl)
{"Ingredient_id": "HBIN012351","Ingredient_name": "6-galloylglucose; beta-d-pyranose-form,me glycoside,o-(3,4-dihydroxybenzoyl)","Alias": "NA","Ingredient_formula": "C21H22O14","Ingredient_Smile": "NA","Ingredient_weight": "498.39","OB_score": "NA","CAS_id": "88847-09-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7565","PubChem_id": "NA","DrugBank_id": "NA"}